Microfluidic Devices Market

Global Market Study on Microfluidic Devices: North America to Lead Market Expansion through 2031

Microfluidic Devices Market Segmented By Glass, Polymer, Silicon Material in In-vitro diagnostics, Pharmaceutical, Medical Devices for Point of care testing, Drug Delivery, Analytical devices, Clinical and veterinary diagnostics, Environment and Industrial

  • June-2021
  • PMRREP2995
  • 107 Pages
  • Healthcare

Market Snapshot

Global microfluidic device demand outlook looks impressive for the years ahead, with the market expected to top US$ 21.5 Bn by the end of 2031. This industry survey by Persistence Market Research expects the microfluidic devices market to surge at a CAGR of around 24% over the forecast period of 2021-2031.

China is expected to hold 6.7% and Japan is expected to account for 10.2% global market share through 2031.

Find Out More about the Report Coverage


Some of the major players in the microfluidic device market:

Key Points Covered in Microfluidic Devices Industry Survey:

  • Market estimates and forecast 2016-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, country-wise, and region-wise analysis
  • Competition mapping and benchmarking
  • Brand share and market share analysis
  • Key product innovations and regulatory climate
  • COVID-19 Impact on microfluidic devices and how to navigate
  • Recommendation on key winning strategies

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recent Advancements in Microfluidic Devices

Growing healthcare research and the need for new developments in different fields have fueled demand for microfluidic devices as they substantially reduce the cost of research.

Researchers at the University of Illinois Chicago have recently developed a new continuous-flow microfluidic device that will aid in the study and research of drug compounds and their crystalline shapes and structures, which are key factors to determine drug stability. This new device will help researchers as well the pharmaceutical companies to evaluate data faster and speed up drug development process substantially.

This COVID-19 pandemic has increased demand for research in microbiologics, and hence, demand for microfluidic devices has also increased. Canada-based manufacturer uFluidix has doubled its manufacturing capacity to meet growing demand for microfluidic devices. This has given further impetus to market expansion, with theCOVID-19 crisis expected to further drive the market to new heights over the coming years.


Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Market Overview

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. It has several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments.

Explore Persistence Market Research’s expertise in promulgation of the business !

Factors Promoting Growth

Globally, the microfluidic devices market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as healthcare at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare.

Additionally, the microfluidic technique has evolved into a new classification of research areas, targeting integration of laboratory protocols into miniaturized devices called lab on chip. Miniaturization reduces the cost for screening compounds in pharmaceutical companies for cell biology problems.

Point of care testing in microfluidic devices is expected to expand at a steady CAGR over the forecast period and emerge as a key contributor to overall market expansion.

Checking Out On Figures

Microfluidic devices offer various advantages for genomics including improved test speed, reduced reagent consumption and efficacy. The global microfluidic devices market was valued at US$ 5.1 Bn in 2020. The market is expected to attain a US$ 21.5 Bn valuation by the end of the year 2031, expanding at a robust CAGR of 24%.

By Geography

North America has the largest share in the global microfluidic devices market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic devices market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.

North America held a significant share of 25.1% in 2020 and is expected to reach a market share of 29% by the end of 2031.

Key Segments Covered in Microfluidic Devices Industry Research

By Material

  • Glass
  • Polymer
  • Silicon

By Industry

  • In-vitro diagnostics
  • Pharmaceutical
  • Medical Devices

By Application

  • Point of care testing
  • Pharmaceutical and life science research
  • Drug Delivery
  • Analytical devices
  • Clinical and veterinary diagnostics
  • Environment and Industrial

By Region

  • North America
  • Europe
  • Asia
  • Rest of the World

- FAQs -

The global microfluidic devices market is expected to reach US$ 6 Bn in 2021.

Global microfluidic device demand outlook is expected to scale up to around US$ 21.5 Bn by 2031.

The microfluidic devices industry expanded at a CAGR of 12% over the past 5 years.

Top 5 players producing microfluidic devices hold a whopping 79% of the global market share.

The North American market for microfluidic devices is expected to grow from a share of 25.1% in 2020 to 29% by the end of 2031.

The U.S., Canada, U.K., Japan, and China are key producers of microfluidic devices.

The European market is expected to surge at a steady CAGR of almost 14% over the forecast period.

China is expected is hold a market share of 6.7% and Japan is expected to account for 10.2% of the global market share by the end of 2031.

Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc, Qiagen NV, Bio-Rad Laboratories, Inc, Fluidigm Corporation, and Abbott Laboratories are major exporters of microfluidic devices.

Demand for microfluidic devices has been majorly driven by the U.S., Canada, China, India, and Japan.


Healthcare Mobility Solutions Market

The healthcare mobility solutions market is anticipated to have a prodigious CAGR of 21.9 % during the period of 2022-2032..

Tissue Processing System Market

Global tissue processing systems market was worth around US$ 280 Mn and is expected to reach a valuation of more than US$ 400 Mn by the end of 2025.

Medical Tourism Market

Global medical tourism market was valued at US$ 162.7 Bn in 2020, and is expected to exhibit a CAGR of 10.2% over the forecast period (2021-2031)..

Fall Detection System Market

Global fall detection system market is anticipated to be valued at US$ 518.5 Mn by 2025 end, expanding at over 4.5% CAGR in terms of value during the forecast period.

Our Clients

Our Clients